Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to -$30.0 million.

  • Icu Medical's Cash from Investing Activities fell 3135.61% to -$30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $114.1 million, marking a year-over-year increase of 22257.59%. This contributed to the annual value of -$89.0 million for FY2024, which is 115.18% down from last year.
  • Icu Medical's Cash from Investing Activities amounted to -$30.0 million in Q3 2025, which was down 3135.61% from $187.5 million recorded in Q2 2025.
  • In the past 5 years, Icu Medical's Cash from Investing Activities registered a high of $187.5 million during Q2 2025, and its lowest value of -$1.9 billion during Q1 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$21.1 million (2021), whereas its average is -$107.2 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 979221.97% in 2022, then soared by 96418.5% in 2025.
  • Quarter analysis of 5 years shows Icu Medical's Cash from Investing Activities stood at -$32.9 million in 2021, then rose by 27.15% to -$24.0 million in 2022, then dropped by 27.72% to -$30.6 million in 2023, then grew by 13.39% to -$26.5 million in 2024, then decreased by 13.12% to -$30.0 million in 2025.
  • Its Cash from Investing Activities stands at -$30.0 million for Q3 2025, versus $187.5 million for Q2 2025 and -$16.8 million for Q1 2025.